Gery P. Guy

12.7k total citations · 7 hit papers
176 papers, 8.6k citations indexed

About

Gery P. Guy is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Gery P. Guy has authored 176 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Public Health, Environmental and Occupational Health, 61 papers in Epidemiology and 53 papers in Economics and Econometrics. Recurrent topics in Gery P. Guy's work include Opioid Use Disorder Treatment (65 papers), Economic and Financial Impacts of Cancer (39 papers) and Health Systems, Economic Evaluations, Quality of Life (31 papers). Gery P. Guy is often cited by papers focused on Opioid Use Disorder Treatment (65 papers), Economic and Financial Impacts of Cancer (39 papers) and Health Systems, Economic Evaluations, Quality of Life (31 papers). Gery P. Guy collaborates with scholars based in United States, Kenya and Uganda. Gery P. Guy's co-authors include Donatus U. Ekwueme, K. Robin Yabroff, Jan L. Losby, Meg Watson, Lisa C. Richardson, Dawn M. Holman, Randall Young, Kun Zhang, Steven R. Machlin and Chunyu Li and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gery P. Guy

167 papers receiving 8.4k citations

Hit Papers

Vital Signs: Changes in Opioid Prescribing in the United ... 2014 2026 2018 2022 2017 2014 2015 2015 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
    2017 882 citations Gery P. Guy, Kun Zhang et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011
    2014 614 citations Gery P. Guy, Donatus U. Ekwueme et al. American Journal of Preventive Medicine profile →
  3. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.
    2015 425 citations Gery P. Guy, Cheryll C. Thomas et al. PubMed profile →
  4. Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors
    2015 407 citations K. Robin Yabroff, Emily C. Dowling et al. Journal of Clinical Oncology profile →
  5. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline
    2018 286 citations Amy S. B. Bohnert, Gery P. Guy et al. Annals of Internal Medicine profile →
  6. Chronic Pain Among Adults — United States, 2019–2021
    2023 237 citations S. Michaela Rikard, Andrea E. Strahan et al. MMWR Morbidity and Mortality Weekly Report profile →
  7. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017
    2019 183 citations Gery P. Guy, Christina A. Mikosz et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gery P. Guy United States 46 2.9k 2.4k 2.2k 1.9k 1.5k 176 8.6k
Martin Vessey United Kingdom 72 4.8k 1.6× 2.1k 0.9× 1.6k 0.7× 482 0.3× 164 0.1× 233 16.1k
Samuel Shapiro United States 58 2.3k 0.8× 1.6k 0.7× 1.0k 0.5× 172 0.1× 411 0.3× 184 10.9k
Rachael L. Morton Australia 43 1.8k 0.6× 1.1k 0.5× 984 0.4× 1.2k 0.6× 258 0.2× 241 8.8k
A Toby Prevost United Kingdom 55 2.1k 0.7× 761 0.3× 1.1k 0.5× 394 0.2× 148 0.1× 236 9.3k
Aminah Jatoi United States 50 1.1k 0.4× 4.6k 1.9× 901 0.4× 398 0.2× 366 0.2× 400 13.6k
Matthew M. Zack United States 54 1.3k 0.4× 1.8k 0.7× 2.3k 1.0× 562 0.3× 63 0.0× 173 11.3k
William Dale United States 53 1.8k 0.6× 3.0k 1.2× 575 0.3× 1.7k 0.9× 37 0.0× 267 10.0k
Philip C Hannaford United Kingdom 45 2.0k 0.7× 782 0.3× 574 0.3× 446 0.2× 47 0.0× 171 7.7k
Bruno Giraudeau France 49 888 0.3× 592 0.2× 1.1k 0.5× 624 0.3× 158 0.1× 264 7.5k
David K. Blough United States 47 1.0k 0.3× 1.2k 0.5× 1.3k 0.6× 2.0k 1.0× 55 0.0× 115 9.3k

Countries citing papers authored by Gery P. Guy

Since Specialization
Citations

This map shows the geographic impact of Gery P. Guy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gery P. Guy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gery P. Guy more than expected).

Fields of papers citing papers by Gery P. Guy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gery P. Guy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gery P. Guy. The network helps show where Gery P. Guy may publish in the future.

Co-authorship network of co-authors of Gery P. Guy

This figure shows the co-authorship network connecting the top 25 collaborators of Gery P. Guy. A scholar is included among the top collaborators of Gery P. Guy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gery P. Guy. Gery P. Guy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terranella, Andrew, et al.. (2025). Gabapentinoid Dispensing to Children and Adolescents in the U.S.. American Journal of Preventive Medicine. 68(5). 1022–1027.
2.
Guy, Gery P., Christopher M. Jones, S. Michaela Rikard, et al.. (2025). Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access. Journal of Addiction Medicine. 19(5). 615–620. 1 indexed citations
3.
García, Macarena C., Lauren M. Rossen, Karen A. Matthews, et al.. (2024). Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022. PubMed. 73(2). 1–11. 15 indexed citations
4.
5.
Connolly, Sarah, Xinyi Jiang, Andrew Terranella, et al.. (2024). Characteristics of Alcohol, Marijuana, and Other Drug Use Among Persons Aged 13–18 Years Being Assessed for Substance Use Disorder Treatment — United States, 2014–2022. MMWR Morbidity and Mortality Weekly Report. 73(5). 93–98. 5 indexed citations
6.
Underwood, Natasha, et al.. (2024). Barriers to retention in medications for opioid use disorder treatment in real-world practice. Journal of Substance Use and Addiction Treatment. 160. 209310–209310. 5 indexed citations
7.
Rikard, S. Michaela, Andrea E. Strahan, Kristine M Schmit, & Gery P. Guy. (2023). Chronic Pain Among Adults — United States, 2019–2021. MMWR Morbidity and Mortality Weekly Report. 72(15). 379–385. 237 indexed citations breakdown →
8.
9.
Rikard, S. Michaela, Andrea E. Strahan, Kristine M Schmit, & Gery P. Guy. (2023). Prevalence of Pharmacologic and Nonpharmacologic Pain Management Therapies Among Adults With Chronic Pain—United States, 2020. Annals of Internal Medicine. 176(11). 1571–1575. 3 indexed citations
10.
Guy, Gery P., et al.. (2023). State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Network Open. 6(9). e2332507–e2332507. 10 indexed citations
11.
Dunphy, Christopher, Kun Zhang, Likang Xu, & Gery P. Guy. (2022). Racial‒Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid. American Journal of Preventive Medicine. 63(5). 717–725. 36 indexed citations
12.
Ng, Boon Peng, Elizabeth M. Rabold, Gery P. Guy, et al.. (2020). Opioid dispensing among adult Medicaid enrollees by diabetes status. Current Medical Research and Opinion. 36(10). 1577–1581. 1 indexed citations
13.
Board, Amy, Gery P. Guy, Christopher M. Jones, & Brooke Hoots. (2020). Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–2019. Drug and Alcohol Dependence. 217. 108297–108297. 47 indexed citations
14.
Guy, Gery P., et al.. (2019). An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015. American Journal of Preventive Medicine. 57(5). 629–636. 19 indexed citations
15.
Nataraj, Nisha, Kun Zhang, Gery P. Guy, & Jan L. Losby. (2019). Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis. Drug and Alcohol Dependence. 197. 250–254. 37 indexed citations
16.
Esser, Marissa B., Gery P. Guy, Kun Zhang, & Robert D. Brewer. (2019). Binge Drinking and Prescription Opioid Misuse in the U.S., 2012–2014. American Journal of Preventive Medicine. 57(2). 197–208. 53 indexed citations
17.
Guy, Gery P., Meg Watson, Andrew B Seidenberg, et al.. (2017). Trends in indoor tanning and its association with sunburn among US adults. Journal of the American Academy of Dermatology. 76(6). 1191–1193. 38 indexed citations
18.
Tangka, Florence K. L., et al.. (2016). Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation. Cancer Causes & Control. 28(1). 41–48. 16 indexed citations
19.
Brown, Derek S., Justin G. Trogdon, Donatus U. Ekwueme, et al.. (2016). Health State Utility Impact of Breast Cancer in U.S. Women Aged 18–44 Years. American Journal of Preventive Medicine. 50(2). 255–261. 9 indexed citations
20.
Guy, Gery P., Donatus U. Ekwueme, K. Robin Yabroff, et al.. (2013). Economic Burden of Cancer Survivorship Among Adults in the United States. Journal of Clinical Oncology. 31(30). 3749–3757. 287 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Vessey Breakdown of academic impact, for papers by Samuel Shapiro Breakdown of academic impact, for papers by Rachael L. Morton Breakdown of academic impact, for papers by A Toby Prevost Breakdown of academic impact, for papers by Aminah Jatoi Breakdown of academic impact, for papers by Matthew M. Zack Breakdown of academic impact, for papers by William Dale Breakdown of academic impact, for papers by Philip C Hannaford Breakdown of academic impact, for papers by Bruno Giraudeau Breakdown of academic impact, for papers by David K. Blough
Rankless by CCL
2026